INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
17/02/2026
Voltar para busca
Dado oficial do USPTO
SVAR
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Snapshot rápido
ST13
US500000079241657Classe
1, 5, 9, 10, 38, 42, 44
Pedido
79241657
Registro
5736546
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
39
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 9, 10, 38, 42, 44
Data de depósito
11/05/2018
Data de registro
30/04/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
17/06/2025
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
708
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
99
Localização do titular
Malmö, SE
Examinador
SHEN, ELIZABETH S
Localização atual
Historical data usage
Titulares e representantes
Titulares
SVAR Life Science AB
Euro-Diagnostica AB
Representantes
Maurine Knutsson Knutsson IP AB
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 10Classe 38Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Substances for use in cell-based reporter gene assaysassays for research purposes; reagents for medical research purposes; reagents for research purposes; reagents for industrial purposesreagents for scientific and research use; reagents for chemical analyseschemical reagents for non-medical purposes; cells and reagents for scientific and research use in testing of pharmaceutical products; cell culture media for scientific and research usecell-lines; components for cell-based analyses using optical methods and containing chemical reagentscells for scientific and research use; chemical preparations for the laboratory and for scientificdiagnostic and analytical purposesother than for medical or veterinary use
Classe 5
Reagents for medical use; diagnostic reagents for medical use; biological reagents for medical use; medical diagnostic reagents and assays for testing of body fluids; diagnostic and analytical substances for medical and veterinary purposesin particularlaboratory diagnostic kits comprised of medical diagnostic reagentsanti-bodiesimmunochemicals for use in disease detection in the area of medical prevention
Classe 9
Instruments for use in performing cell-based assays by means of optic detectionoptical inspection apparatus; computer software for use in performing optic based biological analysis; computer software for use in performing optic based biological analysisfor using tools during drug developmentclinical diagnosisclinical monitoring or assay development; computer application software for mobile phones and handheld computerssoftware for patient monitoring; apparatus for recordingtransmission and reproduction of sound and images; blank magnetic data carriers; digital recording mediablank digital storage media
Classe 10
Medical diagnostic apparatus for testing assays; medical equipmentapparatus for analysing blood
Classe 38
Telecommunication servicestransmission of voicedatagraphicsimagesaudio and video by means of telecommunications networkswireless communication networksthe Internet; providing access to portals on the internet
Classe 42
Cell-based assay servicescustom design and development of cell-based biochemical assays; cell-based assay servicescustom design and development of cell-based biochemical assays for use in drug developmentclinical diagnosisclinical monitoring or assay development; medical research; clinical research in the field of drug developmentclinical diagnosisclinical monitoring or assay development; scientific research; research and development in the field of diagnostic preparations; pharmaceutical drug development services; conducting clinical trials for others; laboratory research and analysis services in the field of drug developmentclinical diagnosisclinical monitoring or assay development; scientific laboratory testing services; research in the fields of medicine and data analytics; providing scientific diagnostic services for others in the fields of drug developmentclinical diagnosisclinical monitoring or assay development ; testing of chemical preparations and cells for diagnostic purposes
Classe 44
Medical testing services relating to measurement and quantification of drug levels and immunogenicity in patient samples for diagnostic or treatment purposes ; medical servicestreating persons based on laboratory analysis; providing medical support in the nature of medical monitoring of patients receiving medical treatments; medical diagnostic testing services
Publicações
Histórico de despachos e eventos da marca no USPTO.
39 publicações encontradas
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
17/06/2025
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
17/06/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
16/06/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/03/2025
ES75
TEAS SECTION 71 & 15 RECEIVED
25/02/2025
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
05/06/2020
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
15/04/2020
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
02/04/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
13/09/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
26/08/2019
FIMP
FINAL DISPOSITION PROCESSED
26/08/2019
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
15/08/2019
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
15/08/2019
PLGL
ASSIGNED TO PARALEGAL
15/08/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
30/07/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
30/04/2019
PUBO
PUBLISHED FOR OPPOSITION
12/02/2019
GPNX
NOTIFICATION PROCESSED BY IB
08/02/2019
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
01/02/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
23/01/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
23/01/2019
NPUB
NOTICE OF PUBLICATION
23/01/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/01/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/12/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/12/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
28/12/2018
RFNT
REFUSAL PROCESSED BY IB
09/11/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
23/10/2018
RFRR
REFUSAL PROCESSED BY MPU
23/10/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/10/2018
CNRT
NON-FINAL ACTION WRITTEN
11/10/2018
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
11/10/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/10/2018
CNRT
NON-FINAL ACTION WRITTEN
10/10/2018
MAFR
APPLICATION FILING RECEIPT MAILED
09/10/2018
DOCK
ASSIGNED TO EXAMINER
03/10/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/10/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
27/09/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SVAR ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.